Filing Details

Accession Number:
0001209191-11-029540
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-18 19:55:53
Reporting Period:
2011-05-09
Filing Date:
2011-05-18
Accepted Time:
2011-05-18 19:55:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920465 La Jolla Pharmaceutical Co LJPC Biological Products, (No Disgnostic Substances) (2836) 330361285
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1354737 Deirdre Gillespie 4365 Executive Drive, Suite 300
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-09 99,166 $0.01 99,166 No 4 M Direct
Common Stock Disposition 2011-05-17 99,166 $0.02 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Series C-1 Convertible Preferred Disposition 2011-05-09 1 $595.00 99,166 $0.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
111 No 4 M Direct
Footnotes
  1. Shares issued on conversion of Series C-1 Convertible Preferred. The Series C-1 Convertible Preferred has a face value of $1,000 per share and was convertible into Common Stock at a ratio of 166,667 shares of Common Stock per share of Series C-1 Convertible Preferred.
  2. Reflects the price following a one-time adjustment on May 7, 2011 after the Company's 100 to 1 reverse split.
  3. Exercisable date is not applicable.
  4. Expiration date is not applicable.